Haisco Pharmaceutical Group Co Ltd (002653):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Haisco Pharmaceutical Group Co Ltd (002653) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7927
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations. The company offers parenteral nutrition drugs, first-aid drugs, antibiotics, anesthetic agents, nervous system drugs, digestive system drugs and tumor adjuvant drugs. Its parenteral nutrition drugs include compound amino acid injection, injectable fat-soluble vitamins, vitamin and trace element drug, invert sugar injection, trace element injection and injectable fat soluble vitamins. Haisco Pharma’s first-aid drugs comprise cefotene hydrochloride, sodium fusidate, cefmetazole sodium, cefmenoxime hydrochloride and cefoperazone sodium tazobactam sodium. The company conducts research and development of drugs in monoclonal antibodies for anticancer, small molecular patent medicine and novel generic drugs. It operates offices in Shannan and Chengdu, China. Haisco Pharma is headquartered in Shannan, China.

Haisco Pharmaceutical Group Co Ltd (002653) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Regentis Biomaterials Raises USD15 Million in Series D Financing Round 10
Medical Surgery Technologies Raises USD12.5 Million in Series C Financing 12
Equity Offering 13
EndoSpan Raises USD10 Million in Private Placement of Shares 13
Acquisition 14
Xizang Haisco Pharma to Acquire 10% Stake in NewPace for USD5 Million 14
Haisco Pharmaceutical Group Co Ltd – Key Competitors 15
Haisco Pharmaceutical Group Co Ltd – Key Employees 16
Haisco Pharmaceutical Group Co Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Key Facts, 2017 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Deals By Market, 2012 to YTD 2018 8
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Regentis Biomaterials Raises USD15 Million in Series D Financing Round 10
Medical Surgery Technologies Raises USD12.5 Million in Series C Financing 12
EndoSpan Raises USD10 Million in Private Placement of Shares 13
Xizang Haisco Pharma to Acquire 10% Stake in NewPace for USD5 Million 14
Haisco Pharmaceutical Group Co Ltd, Key Competitors 15
Haisco Pharmaceutical Group Co Ltd, Key Employees 16
Haisco Pharmaceutical Group Co Ltd, Other Locations 17
Haisco Pharmaceutical Group Co Ltd, Subsidiaries 17

List of Figures
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Haisco Pharmaceutical Group Co Ltd (002653):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Yakult Honsha Co., Ltd.:企業の戦略・SWOT・財務分析
    Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Olin Corporation
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • LG Electronics Inc (066570):電力:M&Aディール及び事業提携情報
    Summary LG Electronics, Inc. (LG Electronics), a subsidiary of LG Corp, manufactures and markets consumer electronics and home appliances. Its product portfolio includes television, monitors, personal computers, audio and video equipment, refrigerators, washing machines, dishwashers, cooking applian …
  • Summit Midstream Partners LP (SMLP):企業の財務・戦略的SWOT分析
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • Transgene Biotek Ltd (526139):企業の財務・戦略的SWOT分析
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes bio-generic drugs and vaccines to treat autoimmune diseases and cancer. The company’s product portfolio includes TrabiDHA, a vegetarian source of DHA (Docosahexaenoic acid), used to manufacture healt …
  • Compagnie Financiere Richemont SA (CFR):企業の財務・戦略的SWOT分析
    Compagnie Financiere Richemont SA (CFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Rovsing AS:企業の戦略・SWOT・財務分析
    Rovsing AS - Strategy, SWOT and Corporate Finance Report Summary Rovsing AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Chicago Bridge & Iron Company NV (CBI)-エネルギー分野:企業M&A・提携分析
    Summary Chicago Bridge & Iron Company N.V. (CB&I) is a provider of technology and infrastructure solutions. Its services include conceptual design, technology, engineering, procurement, modularization, construction, fabrication, commissioning, maintenance, program management and environmental servic …
  • Banyan Tree Holdings Ltd:戦略・SWOT・企業財務分析
    Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Caspian Energy Inc (CKZ.H):石油・ガス:M&Aディール及び事業提携情報
    Summary Caspian Energy Inc (CEI) is an independent upstream oil and gas company. It carries out the exploration, development, and production of oil and gas. and the company, along with its subsidiaries hold interests in Aral Petroleum Capital LLP, which holds an exclusive license to explore and deve …
  • Delta Corporation Limited:企業の戦略・SWOT・財務情報
    Delta Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Delta Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • The Second Cup Ltd.:戦略・SWOT・企業財務分析
    The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Selecta Biosciences Inc (SELB)-製薬・医療分野:企業M&A・提携分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a clinical-stage biopharmaceutical company which develops immunotherapies and vaccines to prevent and treat disease. The company’s pipeline products include SEL-212, SELA-070, SEL-701, LMB-100 and others. Its synthetic vaccine particle (SVP) t …
  • Beijing Shouhang IHW Resources Saving Technology Co Ltd (002665):電力:M&Aディール及び事業提携情報
    Summary Beijing Shouhang IHW Resources Saving Technology Co Ltd (Shouhang IHW Resources) is an electrical equipment company that offers heat generation systems. The company designs, manufactures and distributes CSP power generating system, thermal power plant air cooling system, waste heat power gen …
  • Medifocus Inc (MFS):製薬・医療:M&Aディール及び事業提携情報
    Summary Medifocus Inc (Medifocus) is a medical technology company. The company develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate. Its technology platforms includes endo-thermotherapy platform, a catheter-based …
  • NARI Technology Development Co Ltd (600406):企業の財務・戦略的SWOT分析
    NARI Technology Development Co Ltd (600406) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Cayenne Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cayenne Medical Inc (Cayenne Medical), a subsidiary of Zimmer Biomet Holdings Inc, is a soft-tissue reconstruction service provider. The company provides knee and shoulder implant products. It offers products such as aperfix femoral, aperfix II tibial, mirror partial knee, cross fix meniscal …
  • Newmont Corp:企業の戦略・SWOT・財務分析
    Newmont Corp - Strategy, SWOT and Corporate Finance Report Summary Newmont Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Hwange Colliery Co Ltd:企業の戦略・SWOT・財務分析
    Hwange Colliery Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hwange Colliery Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • McDermott International Inc (MDR):電力:M&Aディール及び事業提携情報
    Summary McDermott International Inc (MII) is a provider of integrated engineering, procurement, construction and installation (EPCI), front-end engineering and design (FEED) and module fabrication services for upstream field developments. It delivers fixed and floating production facilities, pipelin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆